Form 4 holding
Chief Executive Officer, Director
Zymeworks Inc.
- Security class
- Common Shares
- Shares / value
- 260,325
- Estimated value
- $1,174,066
- Report date
- 16 Jul 2021
- Price
- $4.51
- Ownership
- Direct
Ali Tehrani
Insider Reports History
- Reporting-owner location
- Vancouver, British Columbia, Canada
- Latest reporting-owner signature
-
/s/ Daniel Dex, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Ali Tehrani
Form 4 holding
Chief Executive Officer, Director
Zymeworks Inc.
- Security class
- Common Shares
- Shares / value
- 55,511
- Estimated value
- $250,355
- Report date
- 15 Jul 2021
- Price
- $4.51
- Ownership
- Held by spouse
Form 4 holding
Chief Executive Officer, Director
Zymeworks Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- Report date
- 16 Jul 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
Insider Reports Filed by Ali Tehrani
4
Zymeworks Inc.
- Report period
- 15 Jul 2021
- Transactions
- 6
- Transaction value
- -$1,427,794
- Accepted by SEC
- 16 Jul 2021, 21:30
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details
4
Zymeworks Inc.
- Report period
- 12 Jul 2021
- Transactions
- 3
- Transaction value
- -$403,079
- Accepted by SEC
- 13 Jul 2021, 20:00
- Role
- Chief Executive Officer, Director
- Next action
- Open filing details